193693-60-6,
Fmoc-L-beta-homoproline,
Fmoc-beta-HoPro-OH,
(S)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid,
FMOC-HOMOPRO-OH,
MFCD01863058,
2-[(2S)-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidin-2-yl]acetic acid,
Fmoc-L-pipecolic acid;Fmoc-Pip-OH,
Fmoc--HoPro-OH Fmoc-L--homoproline,
Fmoc-D-beta-homoproline,
AK162654,
(S)-2-(1-Fmoc-2-pyrrolidinyl)acetic acid,
Fmoc-beta-Homopro-OH,
Fmoc-L-beta-HPro-OH,
Fmoc-I(2)-HoPro-OH,
Fmoc-L-beta3-homoproline,
Fmoc-L-|A-Homo-Pro-OH,
AC1MC56S,
SCHEMBL119493,
CTK0H4813,
DTXSID20375823,
ZINC622106,
CF-332,
AKOS015912160,
(2S)-1-Fmoc-2-pyrrolidineacetic acid,
DS-7891,
FCH2718616,
FL715-1,
AC-22090,
AC-25441,
ACM193693606,
AN-30187,
AX8019120,
RT-012979,
CS-0035439,
FT-0654958,
ST24035854,
V1053,
Fmoc-L-beta3-homoproline, >=98.0% (HPLC),
693F606,
I14-3545,
J-012541,
(2S)-1-(9H-Fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-acetic acid,
[(2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidin-2-yl]acetic acid,
{(2S)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-pyrrolidinyl}acetic acid,
2-[(2S)-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidin-2-yl]ethanoic acid,
2-[(2S)-1-[9H-fluoren-9-ylmethoxy(oxo)methyl]-2-pyrrolidinyl]acetic acid,
2-Pyrrolidineaceticacid, 1-[(9H-fluoren-9-ylmethoxy)carbonyl]-, (2S)-,
Fmoc-|A-HoPro-OH,
C21H21NO4,
ACN-026009,
CID2761542,
Fmoc-(S)-(-)-piperidine-2-carboxylic acid,
N-Fmoc-L-beta-homoproline, 99% - 1G 1g,
(S)-2-Carboxymethyl-pyrrolidine-1-carboxylic acid,
2-Pyrrolidineacetic acid, 1-[(9H-fluoren-9-ylmethoxy)carbonyl]-, (2S)-,
86069-86-5,
2-[1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidin-2-yl]acetic Acid,
193693-61-7,